Introduction: luteinizing hormone for life's journey.
作者信息
Alviggi Carlo, Esteves Sandro C, Fischer Robert, Humaidan Peter
机构信息
Department of Public Health, University of Naples Federico II, Naples, Italy.
Andrology and Human Reproduction Clinic, Campinas, Brazil.
出版信息
Reprod Biol Endocrinol. 2025 Apr 17;23(Suppl 1):59. doi: 10.1186/s12958-025-01357-4.
Abstract
摘要
相似文献
1
Introduction: luteinizing hormone for life's journey.引言：促黄体生成素的生命历程
Reprod Biol Endocrinol. 2025 Apr 17;23(Suppl 1):59. doi: 10.1186/s12958-025-01357-4.
2
From to : A Journey From Life's Simple 7 to Life's Essential 8 and Beyond.从 到 ：从生命的简单七要素到生命的基本八要素及其他。
J Am Heart Assoc. 2022 Nov;11(21):e027658. doi: 10.1161/JAHA.122.027658. Epub 2022 Oct 19.
3
Life's Simple 7 and Peripheral Artery Disease: The Multi-Ethnic Study of Atherosclerosis.生活的 7 要素与外周动脉疾病：动脉粥样硬化的多种族研究。
Am J Prev Med. 2019 Feb;56(2):262-270. doi: 10.1016/j.amepre.2018.09.021. Epub 2018 Dec 13.
4
Comparative Discrimination of Life's Simple 7, Life's Essential 8, and Life's Crucial 9: Evaluating the impact of added complexity on mortality prediction.生命简单七项、生命基本八项和生命关键九项的比较判别：评估增加的复杂性对死亡率预测的影响。
BMC Med. 2025 May 6;23(1):265. doi: 10.1186/s12916-025-04116-9.
5
Association of Life's Simple 7 with incident cardiovascular disease in 53 974 patients with cancer.53974例癌症患者中生命简单七项指标与心血管疾病发病的关联
Eur J Prev Cardiol. 2022 Dec 21;29(18):2324-2332. doi: 10.1093/eurjpc/zwac195.
6
Predictive Value of Cardiovascular Health Score for Health Outcomes in Patients with PCI: Comparison between Life's Simple 7 and Life's Essential 8.心血管健康评分对 PCI 患者健康结局的预测价值：Life's Simple 7 与 Life's essential 8 的比较。
Int J Environ Res Public Health. 2023 Feb 10;20(4):3084. doi: 10.3390/ijerph20043084.
7
American Heart Association's Life's Simple 7 at Middle Age and Prognosis After Myocardial Infarction in Later Life.美国心脏协会的中年生活简单 7 法则与晚年心肌梗死后的预后。
J Am Heart Assoc. 2018 Feb 17;7(4):e007658. doi: 10.1161/JAHA.117.007658.
8
Relationship of the American Heart Association's Impact Goals (Life's Simple 7) With Risk of Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Cohort Study.美国心脏协会的影响目标（生活简单7要素）与慢性肾脏病风险的关系：社区动脉粥样硬化风险（ARIC）队列研究的结果
J Am Heart Assoc. 2016 Apr 6;5(4):e003192. doi: 10.1161/JAHA.116.003192.
9
Comparison of the associations between Life's Essential 8 and Life's Simple 7 with depression, as well as the mediating role of oxidative stress factors and inflammation: NHANES 2005-2018.比较 Life's essential 8 和 Life's Simple 7 与抑郁的关联，以及氧化应激因素和炎症的中介作用：NHANES 2005-2018。
J Affect Disord. 2024 Apr 15;351:31-39. doi: 10.1016/j.jad.2024.01.200. Epub 2024 Jan 26.
10
Associations of psychosocial factors and cardiovascular health measured by Life's Essential 8: The Atherosclerosis Risk in Communities (ARIC) study.心理社会因素与通过 Life's essential 8 测量的心血管健康的关联：动脉粥样硬化风险社区研究 (ARIC)。
PLoS One. 2024 Jul 31;19(7):e0305709. doi: 10.1371/journal.pone.0305709. eCollection 2024.
本文引用的文献
1
The role of recombinant LH in ovarian stimulation: what's new?重组促黄体生成素在卵巢刺激中的作用：有哪些新进展？
Reprod Biol Endocrinol. 2025 Mar 10;23(Suppl 1):38. doi: 10.1186/s12958-025-01361-8.
2
Pharmacogenomic of LH and its receptor: are we ready for clinical practice?促黄体生成素及其受体的药物基因组学：我们准备好应用于临床实践了吗？
Reprod Biol Endocrinol. 2025 Feb 25;23(Suppl 1):29. doi: 10.1186/s12958-025-01359-2.
3
Surfing follicular waves in ovarian stimulation: is there a role for LH in DuoStim protocols? A narrative review and SWOT analysis.卵巢刺激中的卵泡波追踪：促黄体生成素在双刺激方案中起作用吗？一项叙述性综述和SWOT分析。
Reprod Biol Endocrinol. 2025 Feb 25;23(Suppl 1):28. doi: 10.1186/s12958-025-01360-9.
4
The role of LH in follicle development: from physiology to new clinical implications.促黄体生成素在卵泡发育中的作用：从生理学到新的临床意义
Reprod Biol Endocrinol. 2025 Feb 10;23(Suppl 1):22. doi: 10.1186/s12958-025-01353-8.
5
Triggering final follicular maturation for IVF cycles.触发体外受精周期的最终卵泡成熟。
Reprod Biol Endocrinol. 2025 Jan 23;23(Suppl 1):12. doi: 10.1186/s12958-024-01332-5.
6
The role of luteinizing hormone activity in spermatogenesis: from physiology to clinical practice.黄体生成素活性在精子发生中的作用：从生理学到临床实践
Reprod Biol Endocrinol. 2025 Jan 13;23(Suppl 1):6. doi: 10.1186/s12958-024-01333-4.
7
The most appropriate indicators of successful ovarian stimulation.成功进行卵巢刺激的最恰当指标。
Reprod Biol Endocrinol. 2025 Jan 9;23(Suppl 1):5. doi: 10.1186/s12958-024-01331-6.
8
Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials.重组人促黄体生成激素在高龄妇女辅助生殖技术卵巢刺激中的联合治疗：随机对照试验的系统评价和荟萃分析。
Reprod Biol Endocrinol. 2021 Jun 21;19(1):91. doi: 10.1186/s12958-021-00759-4.
9
The Development of Gonadotropins for Clinical Use in the Treatment of Infertility.用于治疗不孕症的临床促性腺激素的发展
Front Endocrinol (Lausanne). 2019 Jul 3;10:429. doi: 10.3389/fendo.2019.00429. eCollection 2019.
10
The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis.重组 LH 在卵巢刺激反应低下的女性中的作用：系统评价和荟萃分析。
Reprod Biol Endocrinol. 2019 Feb 6;17(1):18. doi: 10.1186/s12958-019-0460-4.
Zotero 插件